"Could a new pill help you lose weight safely?"
Foundayo is a new oral weight loss medication that helps people lose significant weight and improve heart health.
The whole archive, filed by the part of life it belongs to — and labelled with how strong the evidence behind it actually is.
Showing 2689–2712 of 3,526
Foundayo is a new oral weight loss medication that helps people lose significant weight and improve heart health.
Lilly has launched Foundayo™ (orforglipron), an oral GLP-1 receptor agonist for weight management, now available in the U.S. This innovative treatment is nota...
Researchers at Case Western Reserve University have identified a significant link between gut bacteria and the progression of Amyotrophic Lateral Sclerosi...
PANoptosis emerges as a critical programmed cell death mechanism in the context of cardiac aging, as highlighted in a recent review. This mode of cell death i...
A recent retrospective cohort study utilizing data from the IQVIA PharMetrics Plus for Academics database has revealed that high-dose inactivated influenza va...
Nanjing Leads Biolabs Co., Ltd. has announced the successful completion of the safety run-in stage of a Phase II clinical trial for its bispecific antibody, O...
Researchers from Kyoto University and RIKEN, led by Osamu Takeuchi and Takuhiro Ito, have uncovered a previously unrecognized layer of genetic regulatio...
The American Speech-Language-Hearing Association (ASHA) is amplifying awareness of vocal health in recognition of World Voice Day on April 16, 2026. With the th...
Ecuador is making significant strides towards becoming one of the first rabies-free countries in Latin America, with a targeted goal to eliminate dog-mediated r...
Kainova Therapeutics has initiated the European expansion of its DOMISOL Phase I/II clinical trial, marking a key milestone in the global development of DT-70...
Recent research from Vanderbilt University Medical Center reveals that both weight loss drugs (specifically GLP-1 receptor agonists like semaglutide and tir...
Researchers at Tokyo University of Science, led by Professor Gen-ichiro Arimura, have unveiled a significant breakthrough in understanding the synergi...
NeuroTherapia, Inc. has successfully completed a 28-day double-masked Phase 2a trial for its oral candidate, NTRX-07, targeting patients with Alzheimer’...
Airna has initiated a Phase 1 clinical trial for AIR-001, an RNA-editing therapeutic targeting alpha-1 antitrypsin deficiency (AATD). The open-label RepAIR1...
AliveCor has achieved regulatory registration in Vietnam for its Kardia 12L electrocardiogram system, which integrates KAI 12L AI technology. This porta...
Boston-based Life Biosciences has successfully closed an $80 million Series D financing, fully subscribed, which will bolster operations through the latter...
Researchers at Flinders University, led by Dr. Witold Bloch, have developed an innovative nano-sized molecular cage that effectively captures short-ch...
Researchers at Johns Hopkins Medicine have identified a critical role for the protein Cystathionine γ-lyase (CSE) in the production of trace amounts of...
A recent survey conducted by Autism BrainNet reveals a significant gap in public understanding regarding the role of brain donation in autism research....
A recent scoping review from the Widening Access to Trials in Care Homes project highlights critical barriers and facilitators to recruiting care home (CH) resi...
A recent analysis from the FIRE trial, involving 1,445 patients aged ≥75 years with myocardial infarction (MI) and multivessel disease, has revealed critica...
A recent study has demonstrated that a single DNA modification in a non-coding region of the X chromosome, specifically enhancer 13 (En13), can induce sex...
A recent multicenter cohort study involving 2,556 hospitalized adults aged 65 and older across five countries (Brazil, Angola, Chile, Colombia, and Portugal) ha...
A recent retrospective multicenter cohort study utilizing the Tianjin Health and Medical Big Data Super Platform has revealed critical insights into glycemic ma...